D. Risk of bias assessment |
|
|
YES |
NO |
Unclear |
Study size |
Was a power calculation performed and adhered? |
|
|
|
Selection bias |
Was the allocation sequence adequately generated? |
|
|
|
Was the patient allocation concealment adequate? |
|
|
|
Detection bias |
Was the length of follow‐up long enough to detect stated outcomes? |
|
|
|
Was the investigator (performer of hormone administration) blinded? |
|
|
|
Was the outcome assessor blinded? |
|
|
|
Were the participants blinded? |
|
|
|
Attrition bias |
Was loss to follow‐up accounted for? |
|
|
|
Was an intention‐to‐treat analysis performed? |
|
|
|
Reporting bias |
Where there any suggestions of selective report of outcome? |
|
|
|
Source of funding |
Is the source of funding stated? |
|
|
|
Remarks: |
|
|
|
|